These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 4808047)
1. Interindividual differences in pharmacokinetics in man: clinical importance. Sjöqvist F Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047 [No Abstract] [Full Text] [Related]
2. Interindividual differences in drug oxidation: clinical importance. Sjöqvist F; von Bahr C Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420 [No Abstract] [Full Text] [Related]
3. Interindividual differences in rates of drug oxidation in man. Davies DS; Thorgeirsson SS; Breckenridge A; Orme M Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412 [No Abstract] [Full Text] [Related]
4. [Inter-individual differences in pharmacokinetics in humans: clinical importance]. Sjöqvist F Minerva Med; 1973 Mar; 64(17):866-79. PubMed ID: 4703858 [No Abstract] [Full Text] [Related]
5. Impairment of drug metabolism in man by allopurinol and nortriptyline. Vesell ES; Passananti GT; Greene FE N Engl J Med; 1970 Dec; 283(27):1484-8. PubMed ID: 4098480 [No Abstract] [Full Text] [Related]
6. [Pharmacokinetics of drugs in the elderly]. Petrin A Int J Clin Pharmacol; 1974 Mar; 9(2):157-9. PubMed ID: 4133294 [No Abstract] [Full Text] [Related]
7. Genetic and environmental factors affecting drug response in man. Vesell ES Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107 [No Abstract] [Full Text] [Related]
8. Assessment of methods to identify sources of interindividual pharmacokinetic variations. Vesell ES; Penno MB Clin Pharmacokinet; 1983; 8(5):378-409. PubMed ID: 6194927 [TBL] [Abstract][Full Text] [Related]
9. Individual differences in the disposition of drugs metabolised in the body. Alvan G Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288 [No Abstract] [Full Text] [Related]
10. A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats. von Bahr C; Alexanderson B; Azarnoff DL; Sjoqvist F; Orrenius S Eur J Pharmacol; 1970 Jan; 9(1):99-105. PubMed ID: 5434299 [No Abstract] [Full Text] [Related]
11. Aspects of drug metabolism relating to pharmacologic activity. Gillette JR Am J Pharm Sci Support Public Health; 1969; 141(2):64-75. PubMed ID: 4979429 [No Abstract] [Full Text] [Related]
12. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man. Gram LF; Andreasen PB; Overo KF; Christiansen J Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758 [TBL] [Abstract][Full Text] [Related]
13. An improved permeability screening technique utilizing the in vitro rat intestine. Blanchard J; Straussner A Acta Pharm Suec; 1977; 14(3):279-86. PubMed ID: 906844 [No Abstract] [Full Text] [Related]
14. Editorial: Drug metabolism in disease. Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718 [No Abstract] [Full Text] [Related]
15. [Bioequivalence of phenylbutazone preparations following a single intramuscular administration]. Weyhenmeyer R; Dingler E; Lohaus R; Mayer D; Teicher H; Wybitul K; Wangemann G; Steim H Arzneimittelforschung; 1984; 34(6):721-3. PubMed ID: 6541493 [TBL] [Abstract][Full Text] [Related]
17. Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics. Paxton JW N Z Med J; 1981 Dec; 94(697):423-5. PubMed ID: 6977751 [No Abstract] [Full Text] [Related]
18. Inhibition of drug metabolism in man. Vesell ES; Passananti GT Drug Metab Dispos; 1973; 1(1):402-10. PubMed ID: 4129869 [No Abstract] [Full Text] [Related]